Tables 2, 3, 4 and 5 summarize the main preclinical and clinical studies on the effects of DPP-4 inhibitors on bone metabolism
Injectable GLP-1 receptor agonists provide predictable absorption of the active drug directly into systemic circulation, resulting in consistent glucose-lowering activity
Any information found on Biotech Peptides is strictly for educational purposes only
1): 180 l of reagent A, 20 l of biomaterial, 8 l of reagent B, and 40 l of trichloroacetic acid solution
The body needs this vital component, which it cannot create on its own
The majority of evidence regarding GLP-1 RAs therapy in patients with steroid-induced dysglycemia originates from cohort studies conducted in solid organ transplant recipients and oncological populations, with a limited number of case reports involving patients with rheumatic diseases